Julian B A, Waldo F B, Rifai A, Mestecky J
Department of Medicine, University of Alabama at Birmingham 35294.
Am J Med. 1988 Jan;84(1):129-32. doi: 10.1016/0002-9343(88)90019-8.
Although its prevalence and clinical importance in the United States are stated to be low, we believe IgA nephropathy occurs as commonly in this country as in Western Europe. Initial reports suggested the disease was perhaps restricted to France and synonymous with "benign recurrent hematuria," but longer follow-up has proven both conclusions incorrect. Obviously, major gaps persist in our understanding of the immunopathogenesis and the natural history. The latency of the American investigative response calls for more intensive clinical and laboratory studies of the most common primary glomerulonephritis worldwide.
尽管在美国其发病率和临床重要性被认为较低,但我们认为IgA肾病在该国的发病率与西欧一样常见。最初的报告表明该疾病可能仅限于法国,等同于“良性复发性血尿”,但更长时间的随访已证明这两个结论都是错误的。显然,我们对免疫发病机制和自然病程的理解仍存在重大差距。美国研究反应的滞后性要求对全球最常见的原发性肾小球肾炎进行更深入的临床和实验室研究。